The tamoxifen derivative ridaifen-B is a high affinity selective CB 2 receptor inverse agonist exhibiting anti-inflammatory and anti-osteoclastogenic effects
Author:
Funder
UAMS Department of Pharmacology and Toxicology
NIH
NIDA
NIAMS
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference67 articles.
1. Cannabinoids in the treatment of cancer;Alexander;Cancer Lett.,2009
2. Emerging therapies for the treatment of osteoporosis;Bhutani;J. Midlife Health,2013
3. Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities;Bosier;Biochem. Pharmacol.,2010
4. A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor/ligand interactions;Bouaboula;J. Biol. Chem.,1997
5. Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors;Brailoiu;Biochemistry (Mosc),2014
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cannabinoid receptors type 2: Function and development in agonist discovery from synthetic and natural sources with applications for the therapy of osteoporosis;Arabian Journal of Chemistry;2024-02
2. N-[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation;Molecules;2022-11-23
3. Multifaceted functions of chronic inflammation in regulating tumor dormancy and relapse;Seminars in Cancer Biology;2022-01
4. Modern approaches to the development of synthetic cannabinoid receptor probes;Pharmacology Biochemistry and Behavior;2021-04
5. Sex differences and the endocannabinoid system in pain;Pharmacology Biochemistry and Behavior;2021-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3